• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

上皮性卵巢癌术后残余病灶:专家意见征询,旨在探讨系统评价和荟萃分析中发表偏倚的潜在影响。

Residual disease after primary surgery for advanced epithelial ovarian cancer: expert elicitation exercise to explore opinions about potential impact of publication bias in a planned systematic review and meta-analysis.

机构信息

Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK

Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.

出版信息

BMJ Open. 2022 Aug 29;12(8):e060183. doi: 10.1136/bmjopen-2021-060183.

DOI:10.1136/bmjopen-2021-060183
PMID:36038183
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9438036/
Abstract

OBJECTIVES

We consider expert opinion and its incorporation into a planned meta-analysis as a way of adjusting for anticipated publication bias. We conduct an elicitation exercise among eligible British Gynaecological Cancer Society (BGCS) members with expertise in gynaecology.

DESIGN

Expert elicitation exercise.

SETTING

BGCS.

PARTICIPANTS

Members of the BGCS with expertise in gynaecology.

METHODS

Experts were presented with details of a planned prospective systematic review and meta-analysis, assessing overall survival for the extent of excision of residual disease (RD) after primary surgery for advanced epithelial ovarian cancer. Participants were asked views on the likelihood of different studies (varied in the size of the study population and the RD thresholds being compared) not being published. Descriptive statistics were produced and opinions on total number of missing studies by sample size and magnitude of effect size estimated.

RESULTS

Eighteen expert respondents were included. Responders perceived publication bias to be a possibility for comparisons of RD <1 cm versus RD=0 cm, but more so for comparisons involving higher volume suboptimal RD thresholds. However, experts' perceived publication bias in comparisons of RD=0 cm versus suboptimal RD thresholds did not translate into many elicited missing studies in Part B of the elicitation exercise. The median number of missing studies estimated by responders for the main comparison of RD<1 cm versus RD=0 cm was 10 (IQR: 5-20), with the number of missing studies influenced by whether the effect size was equivocal. The median number of missing studies estimated for suboptimal RD versus RD=0 cm was lower.

CONCLUSIONS

The results may raise awareness that a degree of scepticism is needed when reviewing studies comparing RD <1 cm versus RD=0 cm. There is also a belief among respondents that comparisons involving RD=0 cm and suboptimal thresholds (>1 cm) are likely to be impacted by publication bias, but this is unlikely to attenuate effect estimates in meta-analyses.

摘要

目的

我们认为专家意见及其纳入计划中的荟萃分析是一种调整预期发表偏倚的方法。我们在具有妇科专长的合格英国妇科癌症学会(BGCS)成员中进行了一项启发式研究。

设计

专家启发式研究。

地点

BGCS。

参与者

具有妇科专长的 BGCS 成员。

方法

专家们获得了一项计划中的前瞻性系统评价和荟萃分析的详细信息,评估了原发性手术治疗晚期上皮性卵巢癌后残留疾病(RD)切除范围对总生存的影响。参与者被要求对不同研究(研究人群大小和比较的 RD 阈值不同)未发表的可能性发表意见。生成了描述性统计数据,并根据样本量和效应大小估计值估算了缺失研究的总数。

结果

纳入了 18 位专家应答者。应答者认为 RD<1cm 与 RD=0cm 之间的比较存在发表偏倚的可能性,但涉及更高体积的次优 RD 阈值的比较则更有可能存在发表偏倚。然而,专家对 RD=0cm 与次优 RD 阈值之间的比较中存在发表偏倚的看法,并没有转化为启发式研究第二部分中许多缺失的研究。应答者估计的主要比较 RD<1cm 与 RD=0cm 的缺失研究中位数为 10(IQR:5-20),缺失研究的数量受效应大小是否不确定的影响。对于次优 RD 与 RD=0cm 的比较,估计的缺失研究中位数较低。

结论

结果可能会引起人们的注意,即在比较 RD<1cm 与 RD=0cm 的研究时,需要一定程度的怀疑。应答者还认为,涉及 RD=0cm 和次优阈值(>1cm)的比较可能受到发表偏倚的影响,但这不太可能削弱荟萃分析中的效应估计值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c57/9438036/9617b797878e/bmjopen-2021-060183f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c57/9438036/9617b797878e/bmjopen-2021-060183f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c57/9438036/9617b797878e/bmjopen-2021-060183f01.jpg

相似文献

1
Residual disease after primary surgery for advanced epithelial ovarian cancer: expert elicitation exercise to explore opinions about potential impact of publication bias in a planned systematic review and meta-analysis.上皮性卵巢癌术后残余病灶:专家意见征询,旨在探讨系统评价和荟萃分析中发表偏倚的潜在影响。
BMJ Open. 2022 Aug 29;12(8):e060183. doi: 10.1136/bmjopen-2021-060183.
2
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
3
Residual Disease After Primary Surgical Treatment for Advanced Epithelial Ovarian Cancer, Part 2: Network Meta-analysis Incorporating Expert Elicitation to Adjust for Publication Bias.原发性手术治疗晚期上皮性卵巢癌后的残留疾病,第 2 部分:纳入专家 elicitation 以调整发表偏倚的网络荟萃分析。
Am J Ther. 2023;30(1):e56-e71. doi: 10.1097/MJT.0000000000001548. Epub 2022 Nov 1.
4
Optimal primary surgical treatment for advanced epithelial ovarian cancer.晚期上皮性卵巢癌的最佳初次手术治疗
Cochrane Database Syst Rev. 2011 Aug 10;2011(8):CD007565. doi: 10.1002/14651858.CD007565.pub2.
5
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
6
Residual Disease Threshold After Primary Surgical Treatment for Advanced Epithelial Ovarian Cancer, Part 1: A Systematic Review and Network Meta-Analysis.原发性手术治疗晚期上皮性卵巢癌后残余病灶阈值:系统评价和网络荟萃分析。第一部分
Am J Ther. 2023;30(1):e36-e55. doi: 10.1097/MJT.0000000000001584. Epub 2022 Dec 20.
7
Systematic lymphadenectomy in the treatment of epithelial ovarian cancer: a meta-analysis of multiple epidemiology studies.系统淋巴结清扫术治疗上皮性卵巢癌:多项流行病学研究的荟萃分析
Jpn J Clin Oncol. 2015 Jan;45(1):49-60. doi: 10.1093/jjco/hyu175. Epub 2014 Nov 11.
8
Models to predict outcomes after primary debulking surgery: Independent validation of models to predict suboptimal cytoreduction and gross residual disease.预测初次肿瘤细胞减灭术后结局的模型:预测不完全肿瘤细胞减灭术和大体残留疾病的模型的独立验证。
Gynecol Oncol. 2019 Jul;154(1):72-76. doi: 10.1016/j.ygyno.2019.04.011. Epub 2019 Apr 16.
9
Incidence and risk factors for postoperative venous thromboembolism in patients with ovarian cancer: Systematic review and meta-analysis.卵巢癌患者术后静脉血栓栓塞症的发生率及危险因素:系统评价和荟萃分析。
Gynecol Oncol. 2021 Feb;160(2):610-618. doi: 10.1016/j.ygyno.2020.11.010. Epub 2020 Nov 19.
10
The role of computed tomography in the assessment of tumour extent and the risk of residual disease after upfront surgery in advanced ovarian cancer (AOC).计算机断层扫描在评估高级卵巢癌(AOC)术前手术后肿瘤范围和残留疾病风险中的作用。
Arch Gynecol Obstet. 2022 Oct;306(4):1235-1243. doi: 10.1007/s00404-022-06466-8. Epub 2022 Mar 2.

引用本文的文献

1
Residual Disease After Primary Surgical Treatment for Advanced Epithelial Ovarian Cancer, Part 2: Network Meta-analysis Incorporating Expert Elicitation to Adjust for Publication Bias.原发性手术治疗晚期上皮性卵巢癌后的残留疾病,第 2 部分:纳入专家 elicitation 以调整发表偏倚的网络荟萃分析。
Am J Ther. 2023;30(1):e56-e71. doi: 10.1097/MJT.0000000000001548. Epub 2022 Nov 1.

本文引用的文献

1
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
2
Individual participant data meta-analysis to examine interactions between treatment effect and participant-level covariates: Statistical recommendations for conduct and planning.个体参与者数据荟萃分析以检验治疗效果与参与者水平协变量之间的相互作用:实施与规划的统计建议
Stat Med. 2020 Jul 10;39(15):2115-2137. doi: 10.1002/sim.8516. Epub 2020 Apr 30.
3
Be positive about negatives-recommendations for the publication of negative (or null) results.
对阴性(或无效)结果的发表持积极态度——阴性结果发表的建议。
Eur Neuropsychopharmacol. 2019 Dec;29(12):1312-1320. doi: 10.1016/j.euroneuro.2019.10.007. Epub 2019 Nov 18.
4
A guide to systematic review and meta-analysis of prognostic factor studies.预后因素研究的系统评价与Meta分析指南
BMJ. 2019 Jan 30;364:k4597. doi: 10.1136/bmj.k4597.
5
Expert Elicitation of Multinomial Probabilities for Decision-Analytic Modeling: An Application to Rates of Disease Progression in Undiagnosed and Untreated Melanoma.专家对多项概率的启发式评估在决策分析模型中的应用:对未诊断和未经治疗的黑色素瘤疾病进展率的应用。
Value Health. 2018 Jun;21(6):669-676. doi: 10.1016/j.jval.2017.10.009. Epub 2017 Dec 8.
6
The preregistration revolution.预注册革命。
Proc Natl Acad Sci U S A. 2018 Mar 13;115(11):2600-2606. doi: 10.1073/pnas.1708274114.
7
Preprint servers facilitate scientific discourse.预印本服务器促进科学交流。
Proc Natl Acad Sci U S A. 2017 Nov 28;114(48):12630. doi: 10.1073/pnas.1716857114. Epub 2017 Oct 19.
8
An increasing problem in publication ethics: Publication bias and editors' role in avoiding it.出版伦理中日益凸显的问题:发表偏倚以及编辑在避免该问题中的作用。
Med Health Care Philos. 2017 Jun;20(2):171-178. doi: 10.1007/s11019-017-9767-0.
9
The physician's experience of changing clinical practice: a struggle to unlearn.医生改变临床实践的经历:一场艰难的摒弃旧习之旅。
Implement Sci. 2017 Feb 28;12(1):28. doi: 10.1186/s13012-017-0555-2.
10
New evidence pyramid.新的证据金字塔
Evid Based Med. 2016 Aug;21(4):125-7. doi: 10.1136/ebmed-2016-110401. Epub 2016 Jun 23.